Anika Therapeutics, Inc. Proceeds from Sale of Other Assets
Anika Therapeutics, Inc. (ANIK) reported Proceeds from Sale of Other Assets of $530.87 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2014-11-06.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfOtherAssets1 · last filed 2014-11-06
- Anika Therapeutics, Inc. proceeds from sale of other assets for the quarter ending 2013-09-30 was $284.08K.
- Anika Therapeutics, Inc. proceeds from sale of other assets for the quarter ending 2013-06-30 was $111.18K.
- Anika Therapeutics, Inc. proceeds from sale of other assets for the quarter ending 2013-03-31 was $135.61K.
| Period end | Proceeds from Sale of Other Assets 3 month | Proceeds from Sale of Other Assets 6 month | Proceeds from Sale of Other Assets 9 month |
|---|---|---|---|
| 2013-09-30 | $284.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $395.26K derived: sum of 2 quarters · filed 2014-11-06 | $530.87K 10-Q · filed 2014-11-06 |
| 2013-06-30 | $111.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $246.78K 10-Q · filed 2014-08-04 | |
| 2013-03-31 | $135.61K 10-Q · filed 2014-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |